Literature DB >> 29669793

Impacts of Prediabetes Mellitus Alone or Plus Hypertension on the Coronary Severity and Cardiovascular Outcomes.

Hui-Hui Liu1, Ye-Xuan Cao1, Sha Li1, Yuan-Lin Guo1, Cheng-Gang Zhu1, Na-Qiong Wu1, Ying Gao1, Qiu-Ting Dong1, Xi Zhao1, Yan Zhang1, Di Sun1, Jian-Jun Li2.   

Abstract

Whether prediabetes mellitus (Pre-DM) alone or combined with hypertension is an independent risk factor for cardiovascular disease has not been fully clarified. This study aimed to further confirm whether the relation of Pre-DM to cardiovascular disease differs between individuals with or without hypertension. A total of 7121 consecutive patients with angina-like chest pain who received coronary angiography were evaluated and 4193 patients with angiography-proven stable, new-onset coronary artery disease were enrolled into the study. They were divided into 3 groups according to diabetes mellitus status and further stratified by hypertension. The severity of coronary artery disease was assessed by number of diseased vessels and Gensini score. All subjects were regularly followed up for the occurrence of the composite end points. Comparisons of coronary artery disease severity and outcomes were performed among these groups. During an average of 11 338 patient-years of follow-up, 434 (10.35%) cardiovascular events occurred. No significant difference was observed in coronary severity and composite end point events between Pre-DM and normal glucose regulation groups (both P>0.05). However, when hypertension was also incorporated as a stratifying factor, cardiovascular disease risk, assessed by coronary severity and clinical prognosis, was significantly elevated in Pre-DM plus hypertension and diabetes mellitus plus hypertension groups, compared with the reference group with normal glucose regulation and normal blood pressure (all P<0.05). The present study indicated that among patients with stable, new-onset coronary artery disease, the increased cardiovascular risk with Pre-DM is largely driven by the coexistence of hypertension rather than Pre-DM per se.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  coronary artery disease; diabetes mellitus; hypertension; prognosis; risk factors

Mesh:

Year:  2018        PMID: 29669793     DOI: 10.1161/HYPERTENSIONAHA.118.11063

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  24 in total

1.  Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in Black Adults: The Jackson Heart Study.

Authors:  Demetria Hubbard; Lisandro D Colantonio; Rikki M Tanner; April P Carson; Swati Sakhuja; Byron C Jaeger; Robert M Carey; Laura P Cohen; Daichi Shimbo; Mark Butler; Alain G Bertoni; Aisha T Langford; John N Booth; Jolaade Kalinowski; Paul Muntner
Journal:  Diabetes Care       Date:  2019-10-07       Impact factor: 19.112

2.  Systolic Blood Pressure, Cardiovascular Mortality, and All-Cause Mortality in Normoglycemia, Prediabetes, and Diabetes.

Authors:  Chao-Lei Chen; Lin Liu; Jia-Yi Huang; Yu-Ling Yu; Kenneth Lo; Yu-Qing Huang; Ying-Qing Feng
Journal:  Diabetes Metab Syndr Obes       Date:  2020-07-06       Impact factor: 3.168

3.  Caffeine and caffeine metabolites in relation to hypertension in U.S. adults.

Authors:  Gerard Ngueta
Journal:  Eur J Clin Nutr       Date:  2019-04-24       Impact factor: 4.016

4.  High-sensitivity C-reactive protein and hypertension: combined effects on coronary severity and cardiovascular outcomes.

Authors:  Hui-Hui Liu; Ye-Xuan Cao; Di Sun; Jing-Lu Jin; Hui-Wen Zhang; Yuan-Lin Guo; Cheng-Gang Zhu; Na-Qiong Wu; Ying Gao; Qiu-Ting Dong; Jian-Jun Li
Journal:  Hypertens Res       Date:  2019-06-25       Impact factor: 3.872

5.  Prediabetes among HIV-infected individuals receiving antiretroviral therapy: prevalence, diagnostic tests, and associated factors.

Authors:  Angsana Phuphuakrat; Hataikarn Nimitphong; Sirimon Reutrakul; Somnuek Sungkanuparph
Journal:  AIDS Res Ther       Date:  2020-05-24       Impact factor: 2.250

6.  Two-hour post-challenge hyperglycemia, but not fasting plasma glucose, associated with severity of coronary artery disease in patients with angina.

Authors:  Chia-Po Fu; Wayne H-H Sheu; Wen-Lieng Lee; Wen-Jane Lee; Jun-Sing Wang; Shih-Yi Lin; I-Te Lee
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

7.  Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status.

Authors:  Jing-Lu Jin; Ye-Xuan Cao; Hui-Hui Liu; Hui-Wen Zhang; Yuan-Lin Guo; Na-Qiong Wu; Cheng-Gang Zhu; Rui-Xia Xu; Ying Gao; Jing Sun; Qian Dong; Jian-Jun Li
Journal:  Cardiovasc Diabetol       Date:  2019-10-14       Impact factor: 9.951

Review 8.  Phenotyping the Prediabetic Population-A Closer Look at Intermediate Glucose Status and Cardiovascular Disease.

Authors:  Elena Barbu; Mihaela-Roxana Popescu; Andreea-Catarina Popescu; Serban-Mihai Balanescu
Journal:  Int J Mol Sci       Date:  2021-06-25       Impact factor: 5.923

9.  Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study.

Authors:  Hui-Wen Zhang; Jing-Lu Jin; Ye-Xuan Cao; Hui-Hui Liu; Yan Zhang; Yuan-Lin Guo; Na-Qiong Wu; Ying Gao; Rui-Xia Xu; Qi Hua; Yan-Fang Li; Chuan-Jue Cui; Geng Liu; Qian Dong; Jing Sun; Jian-Jun Li
Journal:  Cardiovasc Diabetol       Date:  2020-02-10       Impact factor: 9.951

10.  Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.

Authors:  Deshan Yuan; Ping Jiang; Pei Zhu; Sida Jia; Ce Zhang; Yue Liu; Ru Liu; Jingjing Xu; Xiaofang Tang; Xueyan Zhao; Runlin Gao; Yuejin Yang; Bo Xu; Zhan Gao; Jinqing Yuan
Journal:  Cardiovasc Diabetol       Date:  2021-07-16       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.